Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liposic EDO
- Development stage
- Unknown
- Lead developer
- Bausch + Lomb
- Modality
- Small Molecules, Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Liposic EDO is a highly viscous ophthalmic gel formulated for the symptomatic treatment of dry eye syndrome. Its primary active ingredient is carbomer, which acts as a tear substitute and lubricant by forming a protective and moisturizing layer over the ocular surface. This gel mimics natural tears by stabilizing all three layers of the tear film—lipid, aqueous, and mucin—providing long-lasting relief from irritation, burning, or tiredness associated with dry eyes. The formulation also includes cetrimide (as preservative), sorbitol, medium-chain triglycerides for enhanced viscosity and comfort, sodium hydroxide for pH adjustment to match natural tears (pH 7.4), and purified water[1][2][3]. It is particularly suitable for moderate to severe dry eye symptoms and can be used multiple times daily but should not be applied while wearing contact lenses.
- Brand names
- Liposic EDOLiposicLiposic Eye GelLipolac (Spain)Lipovisc (Italy)
- Other names
- carbomer-based lipid-containing artificial tear formulationcarbomer-based lipid-containing gelCBLATCBLC gel
Beyond the preview
Go deeper on Liposic EDO.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liposic EDO.